Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Schrodinger Inc (SDGR)

Schrodinger Inc (SDGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,416,379
  • Shares Outstanding, K 72,859
  • Annual Sales, $ 216,670 K
  • Annual Income, $ 40,720 K
  • EBIT $ -218 M
  • EBITDA $ -213 M
  • 60-Month Beta 1.56
  • Price/Sales 6.54
  • Price/Cash Flow 30.09
  • Price/Book 3.13

Options Overview Details

View History
  • Implied Volatility 59.78% ( -1.26%)
  • Historical Volatility 75.18%
  • IV Percentile 45%
  • IV Rank 27.78%
  • IV High 89.34% on 02/16/24
  • IV Low 48.41% on 05/17/24
  • Put/Call Vol Ratio 0.10
  • Today's Volume 640
  • Volume Avg (30-Day) 693
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 19,153
  • Open Int (30-Day) 17,076

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.25
  • Number of Estimates 5
  • High Estimate 0.03
  • Low Estimate -0.40
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +21.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.61 +4.46%
on 12/19/24
22.83 -14.85%
on 12/02/24
+0.27 (+1.41%)
since 11/20/24
3-Month
16.67 +16.62%
on 10/08/24
23.65 -17.80%
on 11/12/24
-0.41 (-2.07%)
since 09/20/24
52-Week
16.67 +16.62%
on 10/08/24
38.00 -48.84%
on 12/27/23
-14.26 (-42.31%)
since 12/20/23

Most Recent Stories

More News
Health AI Revolution: Experts Predict Major Advancements in AI-Powered Healthcare in 2025

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – Experts predict that artificial intelligence (AI) will soon transition from a novel concept in healthcare...

AVAI : 0.5600 (+1.80%)
GEHC : 78.91 (+1.91%)
SDGR : 19.44 (+0.73%)
MDAI : 1.8900 (+0.53%)
TEM : 35.54 (+7.60%)
3 Small-Cap Stocks to Invest in AI Drug Development

As AI continues to reshape the drug development landscape, here are three promising small-cap biotech stocks worth considering now.

RXRX : 6.03 (-0.99%)
SDGR : 19.44 (+0.73%)
EXAI : 4.84 (+3.20%)
NVDA : 134.70 (+3.08%)
What's the Difference Between Biotech Stocks and TechBio Stocks?

A few enterprising businesses are marketing themselves differently.

DNA : 10.08 (+15.33%)
RXRX : 6.03 (-0.99%)
SDGR : 19.44 (+0.73%)
6 Under-the-Radar AI Stocks That Analysts Expect to Rally

Morgan Stanley is betting on these stocks to benefit from the AI megatrend.

NVDA : 134.70 (+3.08%)
MSFT : 436.60 (-0.10%)
AMZN : 224.92 (+0.73%)
MS : 123.44 (+2.44%)
RXRX : 6.03 (-0.99%)
SDGR : 19.44 (+0.73%)
DH : 4.18 (+0.97%)
RBLX : 60.11 (+2.04%)
SRAD : 16.62 (+0.06%)
SPGI : 491.81 (+1.08%)
Billionaire Bill Gates Has 35% of His Portfolio Invested in These 2 Artificial Intelligence (AI) Stocks: Are They No-Brainer Buys?

AI is a key growth driver for both of these stocks owned by the Gates Foundation Trust.

MSFT : 436.60 (-0.10%)
SDGR : 19.44 (+0.73%)
3 AI-Driven Drug Stocks to Buy Before They Breakout

The pharma sector is expected to undergo a huge disruption, thanks to the impact of artificial intelligence. Here are three companies that Wall Street analysts think could benefit, based on their AI-driven...

NVDA : 134.70 (+3.08%)
GOOGL : 191.41 (+1.54%)
AMZN : 224.92 (+0.73%)
GS : 566.10 (+2.19%)
ABCL : 2.85 (+5.17%)
REGN : 701.85 (-0.90%)
MRNA : 39.39 (-0.43%)
LLY : 767.76 (+1.35%)
NVS : 97.11 (+0.35%)
SDGR : 19.44 (+0.73%)
BMY : 57.33 (+1.83%)
ABSI : 2.99 (+2.40%)
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?

2024 is going to be a sizzler in the biopharma sector.

NVO : 85.00 (-17.83%)
LLY : 767.76 (+1.35%)
PFE : 26.36 (+2.29%)
AZN : 65.35 (+1.41%)
RXRX : 6.03 (-0.99%)
SDGR : 19.44 (+0.73%)
Is Schrödinger Stock a Buy Now?

Its groundbreaking work is winning it some powerful fans, but it's still risky.

LLY : 767.76 (+1.35%)
SDGR : 19.44 (+0.73%)
This Artificial Intelligence (AI) Stock Is Powering the Biotech Revolution: Should You Invest?

There's more to the AI boom than Microsoft and ChatGPT.

BMY : 57.33 (+1.83%)
MSFT : 436.60 (-0.10%)
SDGR : 19.44 (+0.73%)
Why Wall Street Thinks This Artificial Intelligence (AI) Stock Could Skyrocket 140% Over the Next 12 Months

Cathie Wood and Bill Gates like this stock, too.

ZLAB : 26.72 (+1.91%)
ARKG : 23.68 (+3.18%)
SDGR : 19.44 (+0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Schr'dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr'dinger Inc. is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 20.68
2nd Resistance Point 20.26
1st Resistance Point 19.85
Last Price 19.44
1st Support Level 19.02
2nd Support Level 18.60
3rd Support Level 18.19

See More

52-Week High 38.00
Fibonacci 61.8% 29.85
Fibonacci 50% 27.33
Fibonacci 38.2% 24.82
Last Price 19.44
52-Week Low 16.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar